https://www.selleckchem.com/pr....oducts/Gefitinib.htm
It has been suggested that increasing levothyroxine dose to lower TSH levels within the normal laboratory range might be a therapeutic option for patients with apparently well-controlled primary hypothyroidism who are dissatisfied with their treatment and complain of physical or psychological symptoms. This study assessed whether there is a relationship between TSH levels and health-related quality of life (HRQoL) among subjects with adequately treated hypothyroidism. HRQoL was measured with the specific thyroid disease ThyPRO-39 ques
Like
Comment
Share
